Ono Pharmaceutical Announces Termination of Patient Enrollment for Phase III Clinical Trial of Investigational AIDS Drug.Tokyo, Japan, Oct 27, 2005 - (JCNN JCNN Japan Corporate News Network ) - Ono Pharmaceutical announced on October 25 that its clinical trial partner GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ) has notified Ono that the patient enrollment for phase III clinical trials of ONO-4128/873140, an investigational drug for AIDS treatment, has been terminated. The decision was made because the impaired liver function in the phase II clinical trials and the abnormality of liver function test in the recent phase III clinical trial were reported. Specifically, one subject in the phase III trials experienced elevated liver enzymes (AST (AST Computer, Irvine, CA) A PC manufacturer founded in 1980 by Albert Wong, Safi Quershey and Tom Yuen (A, S and T). It offered a complete line of PCs that sold through its dealer channel. , ALT) and total bilirubin Bilirubin The predominant orange pigment of bile. It is the major metabolic breakdown product of heme, the prosthetic group of hemoglobin in red blood cells, and other chromoproteins such as myoglobin, cytochrome, and catalase. . The two companies will discuss whether or not they should proceed with further development. Source: JCN http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion